Clinical Trial Update: Phase 3 Clinical Trial of CartiLife® in Korea [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for CartiLife® in Korea; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defects
• Articular Cartilage Degeneration

Drugs mentioned

• CartiLife

Snippet

Sponsor: Biosolution Co., Ltd. | Conditions: Articular Cartilage Defect, Articular Cartilage Degeneration | Phase 3 | Status: UNKNOWN